(1)
Khalafallah, A. A.; Fernandopulle, B.; Brain, T. Dose-Modified Lenalidomide Induces Sustained Hematological Response in Patients With Intermediate to High Risk Myelodysplasia. Mediterr J Hematol Infect Dis 2010, 2, e2010012.